Pfizer Inc.(NYSE:PFE) may have been a hero in the COVID-19 vaccine race, but its stock is stuck in the slow lane. Down nearly 14% over the last year, the pharma giant's shares have struggled as demand for its pandemic-related treatments has fizzled out.
But things could get interesting—activist investorStarboard Valuejust acquireda $1 billion stake in the company.
Could this signal a turning point for the pharma giant?
Starboard To The Rescue?
Starboard Value, led byJeff Smith, isn't shy about shaking things up. The fund has taken a front-row seat in Pfizer...
Login or create a forever free account to read this news
Sign up/Log in